How much do IVF add-ons cost in Australia?

Individual IVF add-ons range from $200 to $1,500 each. If you said yes to everything a clinic offered, add-ons could add $3,000-8,000 on top of your base IVF cycle. Most patients only need 1-3 add-ons based on their specific diagnosis.

Which IVF add-ons are worth it?

ICSI has strong evidence for male factor infertility. PGT-A has moderate evidence for women 38+ or with recurrent miscarriage. Embryo glue and time-lapse monitoring have moderate evidence and are relatively low cost. Endometrial scratch and intralipid infusions have insufficient evidence and are not recommended.

Is PGT-A worth the cost in Australia?

PGT-A costs $600-1,200 per embryo tested. Evidence supports it for women over 38 and those with recurrent miscarriage. For women under 35 with no history of miscarriage, the cost-benefit is poor. It reduces miscarriage risk but has not been shown to improve overall live birth rates in unselected patients.

Should I pay for ICSI if I don't have male factor infertility?

ICSI costs $1,200-2,000 and has strong evidence for male factor infertility. For non-male-factor cases, evidence shows no benefit over standard insemination. Around 70% of Australian IVF cycles use ICSI, but routine use for all patients is controversial and may add unnecessary cost.

What is embryo glue and does it work?

Embryo glue is a transfer medium enriched with hyaluronic acid that costs $200-500. Moderate evidence suggests a small improvement in implantation rates — roughly 1 in 17 patients may benefit. Its low cost and minimal risk make it a reasonable add-on for most transfers.

IVF Add-Ons Australia 2026: Which Are Worth the Extra Cost?

IVF clinics in Australia offer a growing menu of add-on treatments — each promising to improve your chances. Some are backed by strong evidence. Others have little or none. Saying yes to everything could add $3,000 to $8,000 on top of your base IVF cycle. Here is what the evidence actually says about each one.

All 10 IVF add-ons at a glance

| Add-on | Cost | Evidence | Who should consider | |--------|------|----------|-------------------| | ICSI | $1,200-2,000 | Strong | Male factor, poor fertilisation | | PGT-A | $600-1,200/embryo | Moderate | Age 38+, recurrent miscarriage | | Time-lapse monitoring | $300-800 | Moderate | Multiple embryos, previous poor development | | Embryo glue | $200-500 | Moderate | Any transfer (low cost, low risk) | | Calcium ionophore | $200-400 | Moderate | Repeated fertilisation failure | | Assisted hatching | $200-400 | Weak | Frozen transfers, repeated implantation failure | | ERA | $800-1,500 | Weak | 3+ failed transfers (unproven even then) | | IMSI | $500-1,000 | Weak | Severe teratozoospermia only | | Endometrial scratch | $300-600 | Insufficient | No clear indication | | Intralipid infusions | $300-600 | Insufficient | No clear indication |

If you said yes to every add-on on this list, you would pay an extra $3,000 to $8,000 per cycle on top of the base IVF cost of $7,000 to $15,000. Most patients need only 1 to 3 add-ons based on their specific diagnosis.

What the evidence ratings mean

Strong: Supported by multiple well-designed randomised controlled trials (RCTs). Clear clinical benefit for a defined patient group.
Moderate: Some RCT support. Benefit demonstrated in specific populations but not necessarily for all patients. Low risk and reasonable cost may still make it worthwhile.
Weak: Limited or conflicting evidence. Small or poorly designed studies. Benefit uncertain. Cost may not be justified.
Insufficient: No quality RCT support. Speculative mechanism. Not recommended by NICE, HFEA, or RTAC. Red flag if a clinic presents this as standard.

These ratings align with the HFEA traffic light system (UK) and are informed by Cochrane reviews, NICE guidelines, and published RCTs.

Strong evidence

1. ICSI (Intracytoplasmic Sperm Injection) — $1,200-2,000

What it is: A single sperm is injected directly into the egg, bypassing the natural fertilisation process. Originally developed for severe male factor infertility.

What it costs: $1,200 to $2,000 at Australian clinics. Genea charges the most ($2,200) while Adora Fertility and Number 1 Fertility are at the lower end ($800-1,200).

What the evidence says: Strong evidence for male factor infertility — low sperm count, poor motility, or abnormal morphology. RCTs confirm significantly higher fertilisation rates compared to standard insemination in these cases.

For non-male-factor infertility, a 2019 Cochrane review found no benefit over conventional IVF insemination. Despite this, roughly 70% of all IVF cycles in Australia use ICSI. Routine use adds significant cost without improving outcomes for most patients.

Recommendation: Essential for male factor infertility, previous fertilisation failure, or surgically retrieved sperm. If your partner has a normal semen analysis and you have no history of poor fertilisation, ask your clinic why ICSI is being recommended — standard insemination may be equally effective and $1,200-2,000 cheaper.

Moderate evidence

2. PGT-A (Preimplantation Genetic Testing) — $600-1,200 per embryo

What it is: A small biopsy is taken from each embryo at the blastocyst stage and tested for chromosomal abnormalities (aneuploidies). Embryos with the correct number of chromosomes are prioritised for transfer.

What it costs: $600 to $1,200 per embryo. If you have 4 embryos tested, that is $2,400 to $4,800 — a substantial addition to your cycle cost. Monash IVF is at the lower end ($600/embryo); Genea and FSWA charge $700-720.

What the evidence says: A 2022 Cochrane review found no clear improvement in live birth rates for unselected patients. The STAR trial (2023) showed PGT-A reduced miscarriage rates but did not improve cumulative live birth rates.

For women aged 38 and over, the evidence is more favourable. Older eggs have a much higher rate of aneuploidy, and PGT-A can reduce the number of transfers needed by avoiding aneuploid embryos. It is also reasonable for patients with recurrent miscarriage (2 or more losses) where chromosomal abnormality is a likely cause.

Recommendation: Worthwhile for women 38+ and those with recurrent miscarriage. For women under 35 with no history of loss, the cost-benefit is poor — most embryos are chromosomally normal at that age. Be cautious of clinics that recommend PGT-A for all patients regardless of age or history.

3. Time-Lapse Embryo Monitoring (EmbryoScope) — $300-800

What it is: Embryos are cultured in a specialised incubator with a built-in camera that takes thousands of images during development. AI algorithms analyse the time-lapse footage to score embryo viability and help embryologists select the best embryo for transfer.

What it costs: $300 to $800. Relatively affordable compared to other add-ons. Offered at most major clinics including Genea, IVFAustralia, Melbourne IVF, and Monash IVF.

What the evidence says: The TIME trial (2020) and a 2023 Cochrane review found moderate-quality evidence that time-lapse may improve embryo selection, but the effect on live birth rates is not conclusive. One potential benefit is the undisturbed culture conditions — embryos are not removed from the incubator for daily observation, which may improve the culture environment.

Recommendation: Reasonable add-on at the lower end of the cost spectrum. Most useful when you have multiple embryos and selection matters. Less useful if you only have 1-2 embryos. Should not be marketed as improving embryo quality — it is a selection tool only.

4. Embryo Glue (Hyaluronic Acid) — $200-500

What it is: A transfer medium enriched with hyaluronic acid that may improve embryo implantation by mimicking the natural uterine environment. Applied during the embryo transfer procedure.

What it costs: $200 to $500. One of the cheapest add-ons available. Widely offered across Australian clinics.

What the evidence says: A large Cochrane review (Bontekoe et al., 2014) found a small but statistically significant improvement in clinical pregnancy and live birth rates. The number needed to treat (NNT) is approximately 17 — meaning roughly 1 in 17 patients will benefit. NICE and HFEA rate this as having moderate evidence.

Recommendation: At $200-500 with minimal risk, this is one of the more defensible add-ons. The benefit is small but real. Reasonable for any embryo transfer.

5. Calcium Ionophore (Artificial Oocyte Activation) — $200-400

What it is: A brief chemical exposure of eggs to calcium ionophore after ICSI to trigger the activation cascade that initiates fertilisation. Addresses a specific condition — oocyte activation failure — where eggs fail to respond normally to sperm entry.

What it costs: $200 to $400. Low cost and targeted.

What the evidence says: A 2020 systematic review (Sfontouris et al.) showed significantly improved fertilisation rates in patients with prior complete fertilisation failure after ICSI. This is moderate evidence for a specific, diagnosable condition. Not studied for routine use.

Recommendation: Appropriate and evidence-based for patients with complete fertilisation failure in a previous ICSI cycle, or very low fertilisation rates (under 30%) despite adequate sperm and egg numbers. Should not be offered routinely to first-time patients.

Weak evidence

6. Assisted Hatching — $200-400

What it is: A small hole is made in the embryo's outer shell (zona pellucida) using a laser. The theory is that some embryos — particularly frozen-thawed ones or those from older women — may have a thickened shell that prevents natural hatching and implantation.

What it costs: $200 to $400.

What the evidence says: A 2020 Cochrane review found very low-quality evidence of a small benefit in clinical pregnancy rates, mainly for frozen embryo transfers and patients with previous implantation failure. No significant benefit in unselected populations. NICE does not recommend routine use.

Recommendation: May be worth considering for frozen embryo transfer cycles or after 3+ failed transfers. Not recommended for fresh transfer cycles in first-time patients.

7. ERA (Endometrial Receptivity Analysis) — $800-1,500

What it is: A biopsy of the uterine lining is analysed for gene expression to determine the optimal day for embryo transfer. The test claims to personalise the transfer window based on 248 genes.

What it costs: $800 to $1,500. One of the most expensive add-ons.

What the evidence says: The ERA-RCT (Simon et al., 2020, n=458) found no difference in live birth rates between ERA-guided and standard transfer timing. A 2023 meta-analysis confirmed no benefit for unselected patients. Even for recurrent implantation failure, evidence is limited.

Recommendation: Difficult to justify at $800-1,500 given the evidence. Only consider after 3+ failed transfers of good-quality embryos where all other causes have been excluded. Be sceptical of clinics that recommend ERA routinely.

8. IMSI (High-Magnification ICSI) — $500-1,000

What it is: A refinement of ICSI where sperm are examined at 6,000x magnification (vs 400x for standard ICSI) to select sperm with the best morphology.

What it costs: $500 to $1,000 on top of standard ICSI.

What the evidence says: A 2019 Cochrane review (13 RCTs, n=2775) found very low-quality evidence of no significant difference in live birth rates between IMSI and standard ICSI. Some marginal benefit in cases of severe teratozoospermia. NICE does not recommend routine IMSI.

Recommendation: Only worth considering for severe male factor with very poor sperm morphology and repeated ICSI failure. Standard ICSI achieves comparable results for most patients.

Insufficient evidence

9. Endometrial Scratch — $300-600

What it is: The uterine lining is gently scratched with a catheter in the cycle before embryo transfer. The theory is that the healing response improves implantation. The procedure is mildly to moderately uncomfortable.

What it costs: $300 to $600.

What the evidence says: The PIP trial (Lensen et al., 2019, NEJM, n=1364) — a large, well-designed RCT — found no benefit in live birth rates. A 2021 Cochrane review confirmed no improvement. NICE and HFEA do not recommend endometrial scratch. Many evidence-based clinics have stopped offering it.

Recommendation: Not recommended. The evidence is clear that endometrial scratch does not improve IVF outcomes. If a clinic recommends this as a standard add-on, treat it as a red flag for evidence-poor practice.

The endometrial scratch was once widely offered across Australian IVF clinics. After the landmark PIP trial in 2019 showed no benefit, evidence-based clinics have withdrawn it. If your clinic still recommends it, ask them to explain the evidence.

10. Intralipid Infusions — $300-600

What it is: An intravenous infusion of a soybean oil emulsion given before or around embryo transfer. The theory is that it modulates natural killer (NK) cell activity in the uterus, preventing immune rejection of the embryo.

What it costs: $300 to $600 per infusion.

What the evidence says: No published RCTs support intralipid use in IVF. The underlying theory — that elevated NK cells cause implantation failure — is itself unproven. Blood NK cell levels do not reflect uterine immune activity. RTAC and RANZCOG do not recommend immune therapies for IVF.

Recommendation: Not recommended. This is one of the clearest red-flag add-ons. There is no quality evidence supporting its use. Patients should seek a second opinion if a clinic recommends intralipid infusions or NK cell testing as part of IVF treatment.

Red flags: when a clinic is pushing add-ons

Watch for these warning signs:

Recommending add-ons with insufficient evidence (endometrial scratch, intralipid infusions) as standard practice
Defaulting to ICSI for all patients regardless of semen analysis — this adds $1,200-2,000 without benefit for non-male-factor cases
Recommending PGT-A for women under 35 with no history of miscarriage or failed transfers
Bundling multiple add-ons into a package without explaining the evidence for each one individually
Offering immune testing (NK cells, cytokines) and then recommending treatment based on the results — the tests are not validated for fertility

The RTAC Code of Practice requires clinics to provide evidence-based information about add-on treatments. Ask your clinic to explain the evidence for any recommended add-on and to provide the specific RCTs or guidelines that support it.

The 3-4 add-ons most commonly worth paying for

If you are trying to decide which add-ons to accept, these are the ones with the strongest cost-benefit ratio for the right patients:

ICSI ($1,200-2,000) — if you have male factor infertility or previous fertilisation failure. Not needed for everyone.
Embryo glue ($200-500) — small benefit, low cost, minimal risk. Reasonable for any transfer.
Time-lapse monitoring ($300-800) — useful when you have multiple embryos. Low cost relative to potential selection benefit.
PGT-A ($600-1,200/embryo) — if you are 38+ or have recurrent miscarriage. Not justified for younger women with no history of loss.

Total for these 4: approximately $2,300-4,500. That is a reasonable addition to a base IVF cycle and represents the add-ons with the strongest evidence base.

Total cost if you said yes to everything

| Add-on | Cost | |--------|------| | ICSI | $1,200-2,000 | | PGT-A (4 embryos) | $2,400-4,800 | | Time-lapse monitoring | $300-800 | | Embryo glue | $200-500 | | Calcium ionophore | $200-400 | | Assisted hatching | $200-400 | | ERA | $800-1,500 | | Endometrial scratch | $300-600 | | Intralipid infusions | $300-600 | | IMSI | $500-1,000 | | Total add-ons | $6,400-12,600 |

On top of a base IVF cycle at $7,000-15,000, this would bring your total to $13,400-27,600 for a single cycle. No patient should be paying for all of these. A tailored approach based on your diagnosis, age, and history is essential.

Compare IVF cycle prices, add-on fees, and success rates at 14 RTAC-accredited Australian clinics.

Compare IVF clinics in Australia prices

Key takeaways

Only ICSI has strong evidence, and only for male factor infertility
PGT-A, embryo glue, time-lapse monitoring, and calcium ionophore have moderate evidence for specific patient groups
Endometrial scratch and intralipid infusions have no quality evidence and are not recommended
Ask your clinic to justify each recommended add-on with specific evidence
Budget $2,000-5,000 for evidence-based add-ons on top of your base cycle cost
If a clinic recommends 5+ add-ons for a first cycle, consider getting a second opinion